Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | PDE4A | P27815 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | APLNR | P35414 | 2/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6741377 | 1.00 | L3MBTL1 (0.43) | L3MBTL1LMNATDP1KDM4EPDE4A | |
| SCHEMBL6744312 | 1.00 | L3MBTL1 (0.43) | L3MBTL1LMNATDP1KDM4EPDE4A | |
| SCHEMBL6743153 | 1.00 | L3MBTL1 (0.43) | L3MBTL1LMNATDP1KDM4EPDE4A | |
| SCHEMBL6741431 | 1.00 | L3MBTL1 (0.43) | L3MBTL1LMNATDP1KDM4EPDE4A | |
| SCHEMBL6743645 | 1.00 | L3MBTL1 (0.43) | L3MBTL1LMNATDP1KDM4EPDE4A | |
| SCHEMBL5596018 | 1.00 | L3MBTL1 (0.43) | L3MBTL1LMNATDP1KDM4EPDE4A | |
| SCHEMBL6740419 | 1.00 | L3MBTL1 (0.43) | L3MBTL1LMNATDP1KDM4EPDE4A | |
| SCHEMBL6740171 | 1.00 | L3MBTL1 (0.43) | L3MBTL1LMNATDP1KDM4EPDE4A | |
| SCHEMBL28291225 | 0.89 | LMNA (0.34) | L3MBTL1LMNATDP1KDM4E | |
| SCHEMBL8342848 | 0.86 | LMNA (0.35) | L3MBTL1LMNATDP1APLNR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119715830-A | Glucosamine purity detection method and impurity qualitative method | 中国食品药品检定研究院(国家药品监督管理局医疗器械标准管理中心、中国药品检验总所) | 2025-03-28 | — | — | CN | claimed |
| CN-118845781-A | Application of fructosazine and deoxyfructosazine in promoting hair growth, caring hair, and preventing alopecia | 大连理工大学 | 2024-10-29 | — | — | CN | claimed |
| CN-118184589-A | Preparation process of deoxyfructosazine and application of deoxyfructosazine and fructosazine in cosmetics | 大连理工大学 | 2024-06-14 | — | — | CN | claimed |
| US-20240074481-A1 | CAPSULE-CONTAINING POUCHED PRODUCT FOR ORAL USE | REYNOLDS TOBACCO CO R (US) | 2024-03-07 | — | — | US | claimed |
| CN-112679443-B | Preparation method and application of fructosazine | 大连理工大学 | 2022-06-14 | — | — | CN | claimed |
| US-11344057-B2 | Capsule-containing pouched product for oral use | R.J. REYNOLDS TOBACCO COMPANY (US) | 2022-05-31 | — | — | US | claimed |
| US-20220030928-A1 | CAPSULE-CONTAINING POUCHED PRODUCT FOR ORAL USE | REYNOLDS TOBACCO CO R (US) | 2022-02-03 | — | — | US | claimed |
| CN-119715830-B | Glucosamine purity detection method and impurity qualitative method | 中国食品药品检定研究院(国家药品监督管理局医疗器械标准管理中心、中国药品检验总所) | 2026-03-03 | — | — | CN | disclosed |
| CN-121085857-A | Synthesis method of fructosazine | 大连理工大学 | 2025-12-09 | — | — | CN | disclosed |
| CN-121085857-A | Synthesis method of fructosazine | 大连理工大学 | 2025-12-09 | — | — | CN | disclosed |
| CN-120334433-A | Determination method for glucosamine sulfate capsule related impurities | 河南羚锐制药股份有限公司 | 2025-07-18 | — | — | CN | disclosed |
| CN-119715830-A | Glucosamine purity detection method and impurity qualitative method | 中国食品药品检定研究院(国家药品监督管理局医疗器械标准管理中心、中国药品检验总所) | 2025-03-28 | — | — | CN | disclosed |
| CN-119715830-A | Glucosamine purity detection method and impurity qualitative method | 中国食品药品检定研究院(国家药品监督管理局医疗器械标准管理中心、中国药品检验总所) | 2025-03-28 | — | — | CN | disclosed |
| US-20220264931-A1 | CAPSULE-CONTAINING POUCHED PRODUCT FOR ORAL USE | REYNOLDS TOBACCO CO R (US) | 2022-08-25 | — | — | US | disclosed |
| CN-114901086-A | Tobacco treatment | 英美烟草(投资)有限公司 | 2022-08-12 | — | — | CN | disclosed |
| CN-112679443-B | Preparation method and application of fructosazine | 大连理工大学 | 2022-06-14 | — | — | CN | disclosed |
| CN-112679443-B | Preparation method and application of fructosazine | 大连理工大学 | 2022-06-14 | — | — | CN | disclosed |
| CN-112679443-B | Preparation method and application of fructosazine | 大连理工大学 | 2022-06-14 | — | — | CN | disclosed |
| US-11344057-B2 | Capsule-containing pouched product for oral use | R.J. REYNOLDS TOBACCO COMPANY (US) | 2022-05-31 | — | — | US | disclosed |
| US-20220030928-A1 | CAPSULE-CONTAINING POUCHED PRODUCT FOR ORAL USE | REYNOLDS TOBACCO CO R (US) | 2022-02-03 | — | — | US | disclosed |